Last update : 03 Jul 2025
Patients above 80 eligible for CAR-T therapy
Efficacy of CAR-T administered close to a treatment by anti-CD19 antibody
CAR-T cells after progression/relapse following treatment by bispecific antibody for Spanish and French Patients
CAR-T cells after progression/relapse following treatment by bispecific antibody
Analysis of neurotoxicities following treatment by CAR-T cells
Efficacy and safety of CAR-T in Mantle Cell Lymphoma
Comparison of the safety and efficacy of the two CAR T-cell therapies axi-cel and tisa-cel in DLBCL
Treating transformed Waldenstrom Macroglobulinemia (WM) with CAR T-cells
Analysis of deaths after CAR-T not related to disease progression
CARREL – Outcome of refractory or relapsing patients after CAR T-Cells
Comparison of the safety and efficacy of the two CAR T-cell therapies axi-cel and tisa-cel in large B-cell lymphoma
Use of Tocilizumab in the treatment of Cytokine Release Syndromes – Project with Chugai
IMPA-CT – Impact of CAR-Ts on the health system – Gilead Project
First results of CAR T-cells in real life in lymphoma – Project with BMS
CAR-TRANS – Transfusion needs of patients treated with CAR-T cells